Dr. Moosavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1215 E Michigan Ave
Lansing, MI 48912Phone+1 517-364-1000
Summary
- Dr. Mitchell Moosavi is a pathologist in Lansing, MI and is affiliated with University of Michigan Health-Sparrow Lansing. He received his medical degree from Texas AM Health Science Center College of Medicine and has been in practice 5 years. He specializes in blood banking & transfusion medicine, anatomic pathology, clinical pathology, and clinical informatics and is experienced in coagulation. He has 6 publications and over 30 citations.
Education & Training
Emory University School of MedicineFellowship, Blood Banking/Transfusion Medicine, 2019 - 2020
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 2015 - 2019
Texas A&M; Health Science Center College of MedicineClass of 2015
Certifications & Licensure
GA State Medical License 2019 - 2026
MI State Medical License 2020 - 2026
CA State Medical License 2017 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Clinical Informatics
Publications & Presentations
PubMed
- 19 citationsPassenger Lymphocyte Syndrome; a Review of the Diagnosis, Treatment, and Proposed Detection Protocol.Mitchell M. Moosavi, Alexander Duncan, Sean R. Stowell, John D. Roback, Harold C. Sullivan
Transfusion Medicine Reviews. 2020-07-01 - 1 citationsResolving Blocked Antigen Phenomenon in Hemolytic Disease of the Fetus and Newborn Due to Anti-KMitchell Moosavi, Yao Ma, Janet Baez, Rebecca Jeffreys, D. Ward
Transfusion Medicine Reviews. 2020-02-19 - 10 citationsRetrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.Mitchell M. Moosavi, Melanie Wooten, Abigail L. Goodman, Fadi Nahab, Alexander Duncan
American Journal of Clinical Pathology. 2021-03-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
